| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |